136 related articles for article (PubMed ID: 34859176)
1. Inequality of access to advanced therapies for patients with inflammatory arthritis: a postcode lottery?
Kaul A; Mistry J; Iagnocco A; Baraliakos X; Bosworth A; McNicol I
Rheumatol Adv Pract; 2021; 5(3):rkab081. PubMed ID: 34859176
[TBL] [Abstract][Full Text] [Related]
2. The "postcode lottery" for the surgical correction of gynaecomastia in NHS England.
Stevens RJ; Stevens SG; Rusby JE
Int J Surg; 2015 Oct; 22():22-7. PubMed ID: 26232711
[TBL] [Abstract][Full Text] [Related]
3. Effects of the National Institute for Health and Clinical Excellence's technology appraisals on prescribing and net ingredient costs of drugs in the National Health Service in England.
Dietrich ES
Int J Technol Assess Health Care; 2009 Jul; 25(3):262-71. PubMed ID: 19619344
[TBL] [Abstract][Full Text] [Related]
4. Comanagement with rheumatology and prescription biologics filled during pregnancy in women with rheumatic diseases: a retrospective analysis of US administrative claims data.
Shridharmurthy D; Lapane KL; Baek J; Nunes A; Kay J; Liu SH
BMJ Open; 2022 Dec; 12(12):e065189. PubMed ID: 36549721
[TBL] [Abstract][Full Text] [Related]
5. Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries.
Egeberg A; Rosenø NAL; Aagaard D; Lørup EH; Nielsen ML; Nymand L; Kristensen LE; Thyssen JP; Thomsen SF; Cordtz RL; Loft N; Skov L; Bryld LE; Rasmussen MK; Højgaard P; Kristensen S; Dreyer L
Semin Arthritis Rheum; 2022 Apr; 53():151979. PubMed ID: 35183936
[TBL] [Abstract][Full Text] [Related]
6. Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales: addressing treatment outside the current NICE guidance.
Chiu Y; Ostor AJ; Hammond A; Sokoll K; Anderson M; Buch M; Ehrenstein MR; Gordon P; Steer S; Bruce IN
Clin Rheumatol; 2012 Jun; 31(6):1005-12. PubMed ID: 22271229
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit.
Russell MD; Coath F; Yates M; Bechman K; Norton S; Galloway JB; Ledingham J; Sengupta R; Gaffney K
Rheumatology (Oxford); 2022 Feb; 61(2):734-742. PubMed ID: 33982063
[TBL] [Abstract][Full Text] [Related]
8. Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents.
Kerola AM; Rollefstad S; Kazemi A; Wibetoe G; Sexton J; Mars N; Kauppi M; Kvien TK; Haavardsholm EA; Semb AG
Scand J Rheumatol; 2023 Jan; 52(1):42-50. PubMed ID: 35014920
[TBL] [Abstract][Full Text] [Related]
9. The impact of commissioning for rhinosinusitis in England.
Soni-Jaiswal A; Philpott C; Hopkins C
Clin Otolaryngol; 2015 Dec; 40(6):639-45. PubMed ID: 25851163
[TBL] [Abstract][Full Text] [Related]
10. Views of Directors of Public Health about NICE Appraisal Guidance: results of a postal survey. National Institute for Clinical Excellence.
Davies E; Littlejohns P
J Public Health Med; 2002 Dec; 24(4):319-25. PubMed ID: 12546211
[TBL] [Abstract][Full Text] [Related]
11. A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study.
Dejaco C; Mueller T; Zamani O; Kurtz U; Egger S; Resch-Passini J; Totzauer A; Yazdani-Biuki B; Schwingenschloegl T; Peichl P; Kraus A; Naerr GW
Front Med (Lausanne); 2022; 9():881943. PubMed ID: 35721062
[TBL] [Abstract][Full Text] [Related]
12. Implementation of national body contouring surgery guidelines following massive weight loss: A national cross-sectional survey of commissioning in England.
Dunne JA; Wormald JC; Ghedia R; Soldin M
J Plast Reconstr Aesthet Surg; 2017 Jan; 70(1):54-59. PubMed ID: 27771259
[TBL] [Abstract][Full Text] [Related]
13. NHS commissioning in probation in England - on a wing and a prayer.
Brooker C; Sirdifield C; Ramsbotham LD; Denney D
Health Soc Care Community; 2017 Jan; 25(1):137-144. PubMed ID: 26427348
[TBL] [Abstract][Full Text] [Related]
14. The Challenge for Orphan Drugs Remains: Three Case Studies Demonstrating the Impact of Changes to NICE Methods and Processes and Alternative Mechanisms to Value Orphan Products.
Lee D; McCarthy G; Saeed O; Allen R; Malottki K; Chandler F
Pharmacoecon Open; 2023 Mar; 7(2):175-187. PubMed ID: 36315388
[TBL] [Abstract][Full Text] [Related]
15. Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Uttley L; Bermejo I; Ren S; Martyn-St James M; Wong R; Scott DL; Young A; Stevenson M
Pharmacoeconomics; 2018 Sep; 36(9):1063-1072. PubMed ID: 29546668
[TBL] [Abstract][Full Text] [Related]
16. Provision of NICE-recommended varicose vein treatment in the NHS.
Hitchman LH; Mohamed A; Smith GE; Pymer S; Chetter IC; Forsyth J; Carradice D
Br J Surg; 2023 Jan; 110(2):225-232. PubMed ID: 36448204
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: An observational study using primary care electronic health record data.
Scott IC; Whittle R; Bailey J; Twohig H; Hider SL; Mallen CD; Muller S; Jordan KP
Lancet Reg Health Eur; 2022 Dec; 23():100519. PubMed ID: 36246147
[TBL] [Abstract][Full Text] [Related]
18. Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort Analysis of Claims Data in the United States.
Hopson S; Gibbs LR; Syed S; Low R; McClung L; Beaty S
Adv Ther; 2023 Oct; 40(10):4358-4376. PubMed ID: 37486558
[TBL] [Abstract][Full Text] [Related]
19. Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.
Gossec L; Berenbaum F; Chauvin P; Hudry C; Cukierman G; de Chalus T; Dreuillet C; Saulot V; Tong S; Russo-Marie F; Joubert JM; Saraux A
Clin Rheumatol; 2018 Oct; 37(10):2649-2657. PubMed ID: 29948351
[TBL] [Abstract][Full Text] [Related]
20. Achievement of NICE quality standards for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.
Ledingham JM; Snowden N; Rivett A; Galloway J; Ide Z; Firth J; MacPhie E; Kandala N; Dennison EM; Rowe I
Rheumatology (Oxford); 2017 Feb; 56(2):223-230. PubMed ID: 27694337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
